What's true and what's false about the connections between these often comorbid conditions? These 10 statements will test what you know.
Data from the DPP Outcomes Study reveal a greater than 25% increase in risk for diabetes in this already vulnerable population.
Five slides, 5 snapshots of products that help reduce fingerstick anxiety, enhance medication adherence, and prevent plantar ulcers.
A recent study, the first of its kind, reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are interesting gender differences.
Guidelines say metformin should be stopped where there is acute kidney injury or risk of renal compromise. Now there is evidence to support those recommendations.
To image or not to image: A new study validates professional society recommendations on follow-up strategies for adrenal masses.
The AACE/ACE 2017 recommendations on lipid management renew focus on LDL-C targets, and go far lower than any group has ventured to date.
Significant reductions were seen in MACE, renal disease progression in patients with high CV risk taking canagliflozin.
A large international study found people with highest blood levels of linoleic acid were 35% less likely to develop T2DM than those with the lowest levels.
Can you sort out diabetes facts from fiction? The latest diabetes statistics from the CDC may surprise you.
This tip and 4 others can help you deliver a message that resonates.
At-a-glance: SGLT2 inhibitors, GLP-1 agonists, insulin vs insulin, and more—a look at what’s new, what’s next.
A new open-label randomized controlled trial finds use of CGM in T1DM pregnancies may improve neonatal outcomes.
A new study evaluates the impact of ethnicity on skin autoflourescence used to measure accumulation of atherogenic glycated proteins.
What about those patients who fall into the "gray zone"?